COMMUNIQUÉS West-GlobeNewswire

HLTH Inc. Unveils HLTH.rad — A Bold New Global Gathering for Imaging Innovators Co-Located with HLTH Europe 2026 in Amsterdam
19/06/2025
AMSTERDAM, Netherlands, June 19, 2025 (GLOBE NEWSWIRE) -- HLTH Inc., the leading global platform for health innovation, is proud to announce the launch of HLTH.rad, a groundbreaking new event that will redefine the [...]
OnlineSemaglutide.org Launches Platform Offering Easy Access to GLP-1 Medications
18/06/2025
Revolutionizing Access to Modern Weight-Care Solutions San Diego, CA, June 18, 2025 (GLOBE NEWSWIRE) -- OnlineSemaglutide.org, a leader in the field of Health & Medicine, Women's Health, and Men's Health, is [...]
Galapagos Presented New Data at ICML 2025 From Cohort 3 of ATALANTA-1 in Relapsed/Refractory Indolent NHL Patients, Demonstrating High Complete Response and MRD Negativity Rates With CAR-T Candidate GLPG5101
18/06/2025
Of the 34 patients enrolled in Cohort 3 of the ATALANTA-1 Phase 1/2 study, 32 received GLPG5101; 94% were infused with fresh CAR-T cells, and 93% were treated within seven days of manufacturing GLPG5101 demonstrated [...]
Vincerx Pharma, Inc. Announces Adjournment of Special Meeting - Will Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal
18/06/2025
Failure to approve Dissolution Proposal will reduce or eliminate any potential distributions to stockholders SAN MATEO, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC Pink: VINC) today announced [...]
Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy (GA)
18/06/2025
Dr. Clark Brings 25 Years of Experience Treating Retina Diseases and Developing Emerging Therapies as a Principal Investigator in Over 70 Clinical Trials and as an Early Pioneer of VEGF Inhibitors ANX007 is the Only [...]
Cellectar Biosciences Announces One-for-Thirty Reverse Stock Split
18/06/2025
FLORHAM PARK, N.J., June 18, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of [...]
BrightSpring Health Services Announces Onco360® Selected as National Pharmacy Partner for Multiple New Cancer and Rare Disease Drugs
18/06/2025
LOUISVILLE, Ky., June 18, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) is proud to announce that its specialty pharmacy, Onco360® , has been [...]
Kane Biotech Provides Further Corporate Update
18/06/2025
WINNIPEG, Manitoba, June 18, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) provides updates on its reorganizational phase. The Company has terminated its exclusive [...]
Jyong Biotech Ltd. Announces Closing of $20 Million Initial Public Offering
18/06/2025
New Taipei City, Taiwan, June 18, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative [...]
PSYENCE GROUP INC. Announces Offering of up to C$600,000 Non-Brokered Private Placement of Common Shares
18/06/2025
TORONTO, June 18, 2025 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG) (“ Psyence ” or the “ Company ”), a life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and [...]
Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide
18/06/2025
Company announcement – No. 15 / 2025 Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide Body weight reductions of a mean of 11.6% after 28 [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 mai 2025
18/06/2025
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 mai 2025 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, les [...]
Life Backup Plan App by Galacxia, Inc. Recognized for Great Potential in Pepperdine’s Most Fundable Companies Competition
18/06/2025
Aliso Viejo, CA , June 18, 2025 (GLOBE NEWSWIRE) -- Galacxia, Inc ., developer of the Life Backup Plan digital health platform , proudly announces its advancement to the second round of Pepperdine University’s Most [...]
Excellent Brain Ltd. Announces Joint Venture with MasNeuros to Launch Spanish Neurofeedback Trainers Course
18/06/2025
Excellent Brain Ltd. Expands Global Reach with Spanish Neurofeedback Course Natanya, Israel , June 18, 2025 (GLOBE NEWSWIRE) -- Excellent Brain Ltd., an innovative Israeli start-up renowned for its advanced [...]
Lexicon to Present Data at the 85th Scientific Sessions of the American Diabetes Association (ADA)
18/06/2025
Oral presentation on study demonstrating the ability of sotagliflozin to reduce the risk of hypoglycemic events regardless of kidney function in people with type 1 diabetes THE WOODLANDS, Texas, June 18, 2025 (GLOBE [...]
Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion
18/06/2025
NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]
Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered Target Discovery
18/06/2025
WARREN, N.J., June 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ) today provided an update on its ongoing development of a cytotoxic T lymphocyte (CTL) therapy targeting [...]
Sienna Senior Living Completes Second Acquisition in Ottawa in 2025
18/06/2025
MARKHAM, Ontario, June 18, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA) announced today that it has finalized its previously announced acquisition of Hazeldean Gardens [...]
Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group
18/06/2025
EYEN to bring on major Hyperliquid Thought Leader to support HYPE Treasury Strategy LAGUNA HILLS, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), a pioneer in [...]

Pages